Find your perfect fit.

Great companies are being built by amazing teams. Come be a part of it.
At Menlo Ventures, we invest in companies that will change how we live and work. To do that, they need creative thinkers, problem solvers, builders, and business leaders. They look to Menlo for help building their teams.
Tell us more about your professional DNA to get discovered by the companies we back.

(Sr.) Accountant

Genesis Therapeutics

Genesis Therapeutics

Accounting & Finance
San Diego, CA, USA
Posted on Sunday, June 9, 2024
Role Summary
Genesis Therapeutics is pioneering artificial intelligence guided rational drug design to address severe unmet medical needs for patients. We are hiring an experienced (Sr.) Accountant to join our company in our San Diego, California location. This is an exciting position with the opportunity to play a key role in building and managing the company’s accounting and operations functions. This position reports directly to the Controller.

Maintains the general ledger and performs monthly, quarterly, and annual accounting close process

  • Reconciles accounts including cash, prepaid accounts, fixed assets, accruals, etc.
  • Analyzes account balances and maintains support for the reconciled balances
  • Conducts research of variances and proposes resolution.

Responsible for all aspects of accounts payable function

  • Serves as the primary point of contact for AP.
  • Processes and records all accounts payable transactions.
  • Handles weekly check runs.
  • Reviews credit card transactions to ensure proper coding.

Participates actively in the annual financial audit process

  • Interacts with the auditors on audit requests.
  • Assists with preparation of schedules and compiling records for the audit.

Other Responsibilities

  • Assists in due diligence activities and special projects as needed.
  • Performs other duties as may be assigned, including responding to vendor information requests, generating Purchase Order, updating data sheet and working on special projects.


  • Bachelor’s degree in Accounting or related field required
  • 3+ years of progressive accounting experience
  • Biotech company experience preferred but not required
  • Strong knowledge and understanding of U.S. GAAP a plus
  • Exercises strong judgment and integrity
  • Strong interpersonal skills and the ability to communicate effectively across a diverse range of departments and levels including executive management
  • Ability to proactively identify accounting issues and take the initiative to solve challenges

What we offer

  • Competitive Pay
  • Stock Option Eligibility
  • 401(k) Plan
  • Open PTO Policy
  • Paid Company Holidays
  • Free lunch and snacks at our offices
  • Health Care Plan, including Medical, Dental, and Vision, fully covered for the employees
Genesis Therapeutics is a pioneering AI Biotech company focusing on the discovery of novel drugs using unique approaches to both undrugged and underdeveloped targets with the goal of providing new treatments for patients with severe diseases.
Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. In addition, Genesis has announced two AI platform collaborations across a range of therapeutic areas with Genentech and h Eli Lilly, the latter of which entailed a $20M upfront payment with a $670M total deal size. We’ve also been featured in Forbes 30u30 and in Forbes AI 50.
Genesis originated in graph machine learning research in Vijay Pande’s lab at Stanford, when it was joined by legendary drug hunters and biotech entrepreneurs (including Dr. Leonard Bell, founder and CEO of Alexion Pharmaceuticals, acquired by Astra Zeneca for $39Bn; and Peppi Prasit, storied chemist from Merck known for Vioxx, Arcoxia, Singulair, who then went on to found Amira Pharmaceuticals, acquired by BMS, and Inception Sciences). The company is making strong progress in expanding the domain of our AI technology with the advance of our pipeline of best-in-class and first-in-class programs, both internal targets and those in partnership with Genentech and Lilly.